With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Dr Toyoaki Murohara (Nagoya University School of Medicine, Nagoya, Japan) discusses the comparison of valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance (NAGOYA HEART Study)
Filmed during ACC 2011 in New Orleans, LA on April 4.
theheart.org's forum is a sounding board for healthcare providers, clinicians, and researchers, and is not intended to supply answers or advice to patients.We reserve the right to remove posts containing inappropriate language, promotional content, personal agendas or hostile intent, and posts from patients asking for medical advice. To access health and wellness news, support communities, interactive health management tools and more, visit our sister website for health consumers: http://www.webmd.com/
This forum is intended as a frank but respectful dialogue between healthcare providers, clinicians, and physicians. People found to be using a pseudonym will have their posts removed. To amend your username, visit your profile page
You must fill out both the 'Comment title' field and the 'Comment' field when leaving a comment.
